KTP Green Light Prostatectomy Compared With TUR-P in High Risk Patients
Not Applicable
Active, not recruiting
- Conditions
- BPH (Benign Prostatic Hyperplasia)
- Registration Number
- NCT02075736
- Lead Sponsor
- University of Helsinki
- Brief Summary
The purpose of this study is to compare safety and efficacy of Green Light PVP (Photoselective Vaporization of the Prostate) compared to TUR-P in high risk patients
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
- Men with anticoagulant medication undergoing surgery for BPH
Exclusion Criteria
- Previous prostate surgery
- Carcinoma of the prostate
- Neurogenic bladder
- Bladder carcinoma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Re-bleeding rate requiring hospitalization two months postoperatively
- Secondary Outcome Measures
Name Time Method Length of catheterization Participants will be followed for the duration of hospital stay, an expected maximum of one week Length of hospital stay Participants will be followed for the duration of hospital stay, an expected maximum of one week Perioperative bleeding Time of operation IPSS (International Prostate Symptom Score) 0, 3, 6 and 12 months symptom score
Maximum flow rate (Qmax) 0, 3, 6 and 12 months DAN-PSS (Danish Prostate Symptom Score) 0, 3, 6 and 12 months IIEF (International Index of Erectile Function) questionnaire 0,12 months TRUS (transrectal ultrasound) 0, 12 months Residual urine 0, 3, 6 and 12 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of KTP laser in treating BPH compared to TUR-P?
How does KTP Green Light Prostatectomy compare to TUR-P in terms of long-term clinical outcomes for high-risk BPH patients?
Are there specific biomarkers that predict better response to KTP laser vaporization versus transurethral resection in BPH?
What are the distinct adverse event profiles of KTP laser prostatectomy and TUR-P in high-risk populations?
What are the current trends in laser-based therapies for BPH, and how does the KTP 120W system fit within this landscape?
Trial Locations
- Locations (1)
Helsinki University Hospital
🇫🇮Helsinki, Finland
Helsinki University Hospital🇫🇮Helsinki, Finland